The price of weight-loss drugs has been dropping in 2026. At the same time, employers have been cutting back on their coverage of the drugs.
The recent federal reforms to pharmacy benefit managers are a meaningful step in the right direction, but the work is not ...
Starting October 1, CVS Caremark will include Lilly’s Zepbound in its coverage, while the oral GLP-1 medication Foundayo gains coverage beginning June 1, marking a reversal of last year’s exclusion ...
Eli Lilly and Company just secured a big win as it looks to expand GLP-1 access, mending its partnership with top pharmacy ...
While PBM reforms that passed earlier this year will spur further changes in the way business is conducted, it’s anti-trust ...
PrimeRx reports that independent pharmacies struggle to compete with big retailers like CVS and Walgreens due to pricing ...
CVS Health will reinstate coverage of Eli Lilly's weight-loss injectable Zepbound and begin coverage of the anti-obesity pill ...
Zacks Investment Research on MSN
Here's why Cigna (CI) is a strong value stock
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...
Trump’s executive order on drug pricing means PBM reform is no longer some niche healthcare conversation happening among wonks.
CVS Health sued Tennessee on Friday after Gov. Bill Lee signed a law banning a pharmacy benefit manager from also owning a pharmacy.
Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution. They negotiate rebates, design formularies, adjudicate claims, and steer patient adherence. Modern artificial ...
Cigna said Thursday it will exit the ACA individual health insurance business, leaving health plan members in 11 states looking for new coverage next year.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果